Development of potent pyrazolopyrimidinone-based WEE1 inhibitors with limited single-agent cytotoxicity for cancer therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Donald S. Backos Philip Reigan |
| Publication date | June 8, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |